Remicade at Higher Than Usual Doses Seen as Effective and Safe in Controlling Inflammation in IBD Patients

Remicade at Higher Than Usual Doses Seen as Effective and Safe in Controlling Inflammation in IBD Patients
Higher doses of Remicade (infliximab) can ease the symptoms of inflammatory bowel disease (IBD) by better controlling inflammation with raising the risk of adverse effects — like more infections — in patients, researchers report. Their study, “Success and safety of high infliximab trough levels in inflammatory bowel disease,” was published in the Scandinavian Journal of Gastroenterology. Remicade

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *